Metalloproteinase inhibitor 2
|
Timp2 |
P25785 |
Parkinson Disease
|
Lorenzl, S. et al. (Neurochem Int, 2003)
|
Metalloproteinase inhibitor 2
|
Timp2 |
P30121 |
Parkinson Disease
|
Lorenzl, S. et al. (Neurochem Int, 2003)
|
Natriuretic peptides B
|
Nppb |
P40753 |
Parkinson Disease
|
Watanabe, H. et al. (Neurology, 2009)
|
Lipopolysaccharide-binding protein
|
Lbp |
Q61805 |
Parkinson Disease
|
Hasegawa, S. et al. (PLoS One, 2015)
|
Interleukin-1 receptor antagonist protein
|
Il1rn |
P25085 |
Parkinson Disease
|
Arman, A. et al. (Eur Cytokine Netw, 2010)
|
Interleukin-1 receptor antagonist protein
|
Il1rn |
P25086 |
Parkinson Disease
|
Arman, A. et al. (Eur Cytokine Netw, 2010)
|
Neurotrophin-3
|
Ntf3 |
P20181 |
Parkinson Disease
|
Eberhardt, O. et al. (J Neurosci, 2000), Hurelbrink, C. B. et al. (Expert Opin Pharmacother, 2001), Arenas, E. (Brain Res Bull, 2002), McGrath, J. et al. (Cell Transplant, 2002), Lo Bianco, C. et al. (Neurobiol Dis, 2004), Gasmi, M. et al. (Neurobiol Dis, 2007), Glavaski-Joksimovic, A. et al. (J Neurosci Res, 2010), Bartus, R. T. et al. (Mov Disord, 2011), Drinkut, A. et al. (Mol Ther, 2012), Costello, D. J. et al. (J Cell Mol Med, 2012), Bartus, R. T. et al. (Neurobiol Aging, 2013), Xu, H. et al. (FASEB J, 2013), Sun, X. L. et al. (Mol Neurobiol, 2014), Kotyuk, E. et al. (PLoS One, 2013), Mariani, S. et al. (Rejuvenation Res, 2015)
|
Cytoplasmic aconitate hydratase
|
Aco1 |
P28271 |
Parkinson Disease
|
Faucheux, B. A. et al. (J Neurochem, 2002)
|
Interleukin-10
|
Il10 |
P29456 |
Parkinson Disease
|
Hakansson, A. et al. (Mov Disord, 2005), Infante, J. et al. (Eur J Neurol, 2008), Bialecka, M. et al. (Parkinsonism Relat Disord, 2008), Johnston, L. C. et al. (Mol Ther, 2008), Pascale, E. et al. (Acta Neurol Scand, 2011), Liu, Z. et al. (Sci Rep, 2016)
|
Brain-derived neurotrophic factor
|
Bdnf |
P21237 |
Parkinson Disease
|
Howells, D. W. et al. (Exp Neurol, 2000), Momose, Y. et al. (Ann Neurol, 2002), Guillin, O. et al. (Eur J Pharmacol, 2003), Hong, C. J. et al. (Neurosci Lett, 2003), Parsian, A. et al. (Parkinsonism Relat Disord, 2004), Liu, Q. R. et al. (Am J Med Genet B Neuropsychiatr Genet, 2005), Foltynie, T. et al. (J Neurol, 2005), Nishimura, M. et al. (Mov Disord, 2005), Zintzaras, E. et al. (J Hum Genet, 2005), Karamohamed, S. et al. (Neurology, 2005), Saarela, M. S. et al. (Folia Neuropathol, 2006), Akatsu, H. et al. (Dement Geriatr Cogn Disord, 2006), Xiromerisiou, G. et al. (Neurosci Lett, 2007), Chen, C. M. et al. (Am J Med Genet B Neuropsychiatr Genet, 2007), Altar, C. A. et al. (Neuropsychopharmacology, 2009), Foltynie, T. et al. (J Neurol Neurosurg Psychiatry, 2009), Tong, M. et al. (J Alzheimers Dis, 2009), Zuccato, C. et al. (Nat Rev Neurol, 2009), Guerini, F. R. et al. (Eur J Neurol, 2009), Gao, L. et al. (Acta Neurol Scand, 2010), Fishman-Jacob, T. et al. (Neurodegener Dis, 2010), Somoza, R. et al. (Biol Blood Marrow Transplant, 2010), Lin, C. H. et al. (Parkinsonism Relat Disord, 2011), Chen, L. et al. (Biochem Biophys Res Commun, 2011), Toulouse, A. et al. (Neurotox Res, 2012), Liu, J. et al. (Parkinsonism Relat Disord, 2012), Karakasis, C. et al. (J Clin Neurosci, 2011), Lauterbach, E. C. (Prog Neuropsychopharmacol Biol Psychiatry, 2012), Fu, A. et al. (PLoS One, 2013), Dai, L. et al. (Int J Neurosci, 2013), Sun, X. L. et al. (Mol Neurobiol, 2014), Cheshire, P. et al. (Neurodegener Dis, 2014), Svetel, M. et al. (Eur Neurol, 2013), Lee, Y. H. et al. (J Mot Behav, 2014), Fenner, M. E. et al. (J Mol Histol, 2014), Bialecka, M. et al. (Neurosci Lett, 2014), Kaplan, N. et al. (J Mol Neurosci, 2014), Berg, J. et al. (Stem Cell Rev Rep, 2015), Mariani, S. et al. (Rejuvenation Res, 2015), van der Kolk, N. M. et al. (Neurobiol Aging, 2015), Altmann, V. et al. (Neurosci Lett, 2016), Cagni, F. C. et al. (J Neuropsychiatry Clin Neurosci, 2017), Kang, S. S. et al. (Proc Natl Acad Sci U S A, 2017), Yoshimoto, Y. et al. (Brain Res, 1995)
|
Myelin protein P0
|
Mpz |
P06907 |
Parkinson Disease
|
Veech, G. A. et al. (J Neurosci Res, 2000), Brill, L. B. 2nd et al. (Exp Neurol, 2003), Esteves, A. R. et al. (Mitochondrion, 2008), Duka, T. et al. (FASEB J, 2009), Kim, S. Y. et al. (Neurochem Int, 2010), Guella, I. et al. (Neurobiol Aging, 2011), Piao, Y. et al. (Biochim Biophys Acta, 2012), Dagda, R. K. et al. (Int J Mol Sci, 2013), Zhang, X. M. et al. (Acta Pharmacol Sin, 2014), Choi, D. C. et al. (J Neurosci, 2014)
|
Granulin precursor
|
GRN |
M3YD29 |
Parkinson Disease
|
Brouwers, N. et al. (Arch Neurol, 2007), Rovelet-Lecrux, A. et al. (Neurobiol Dis, 2008), Nuytemans, K. et al. (Neurology, 2008), Jasinska-Myga, B. et al. (Eur J Neurol, 2009), Hsiung, G. Y. R. et al. (, 1993), Antonell, A. et al. (J Alzheimers Dis, 2012), Chang, K. H. et al. (PLoS One, 2013), Mateo, I. et al. (Eur J Neurol, 2013), Carecchio, M. et al. (J Alzheimers Dis, 2014), Van Kampen, J. M. et al. (PLoS One, 2014), Chen, Y. et al. (J Neurol, 2015)
|
Granulins
|
Grn |
P28798 |
Parkinson Disease
|
Brouwers, N. et al. (Arch Neurol, 2007), Rovelet-Lecrux, A. et al. (Neurobiol Dis, 2008), Nuytemans, K. et al. (Neurology, 2008), Jasinska-Myga, B. et al. (Eur J Neurol, 2009), Hsiung, G. Y. R. et al. (, 1993), Antonell, A. et al. (J Alzheimers Dis, 2012), Chang, K. H. et al. (PLoS One, 2013), Mateo, I. et al. (Eur J Neurol, 2013), Carecchio, M. et al. (J Alzheimers Dis, 2014), Van Kampen, J. M. et al. (PLoS One, 2014), Chen, Y. et al. (J Neurol, 2015)
|
CCN family member 2
|
Ccn2 |
Q9R1E9 |
Parkinson Disease
|
McClain, J. A. et al. (Neurosci Lett, 2009)
|
CCN family member 2
|
Ccn2 |
Q53YJ0 |
Parkinson Disease
|
McClain, J. A. et al. (Neurosci Lett, 2009)
|
Peroxiredoxin-5, mitochondrial
|
Prdx5 |
P99029 |
Parkinson Disease
|
De Simoni, S. et al. (Neurosci Lett, 2008)
|
Peroxiredoxin-5, mitochondrial
|
Prdx5 |
Q9R063 |
Parkinson Disease
|
De Simoni, S. et al. (Neurosci Lett, 2008)
|
Phosphatidylethanolamine-binding protein 1
|
Pebp1 |
P70296 |
Parkinson Disease
|
Wen, Z. et al. (Neurobiol Aging, 2014)
|
Phosphatidylethanolamine-binding protein 1
|
Pebp1 |
P31044 |
Parkinson Disease
|
Wen, Z. et al. (Neurobiol Aging, 2014)
|
Peroxiredoxin-2
|
Prdx2 |
Q61171 |
Parkinson Disease
|
Fang, J. et al. (Proc Natl Acad Sci U S A, 2007), Hu, X. et al. (J Neurosci, 2011)
|
Peroxiredoxin-2
|
Prdx2 |
P35704 |
Parkinson Disease
|
Fang, J. et al. (Proc Natl Acad Sci U S A, 2007), Hu, X. et al. (J Neurosci, 2011)
|
Peroxiredoxin-2
|
Prdx2 |
Q6PDV3 |
Parkinson Disease
|
Fang, J. et al. (Proc Natl Acad Sci U S A, 2007), Hu, X. et al. (J Neurosci, 2011)
|
Alpha-L-iduronidase
|
Idua |
P48441 |
Parkinson Disease
|
Narahara, M. et al. (PLoS One, 2014)
|
Glial cell line-derived neurotrophic factor
|
Gdnf |
P48540 |
Parkinson Disease
|
Latchman, D. S. et al. (Mov Disord, 2000), Deglon, N. et al. (Hum Gene Ther, 2000), Bauer, M. et al. (Hum Gene Ther, 2000), Bohn, M. C. et al. (Int J Dev Neurosci, 2000), Kozlowski, D. A. et al. (Exp Neurol, 2000), Eberhardt, O. et al. (J Neurosci, 2000), Ozawa, K. et al. (J Neural Transm Suppl, 2000), During, M. J. et al. (Hum Gene Ther, 2001), Date, I. et al. (Cell Transplant, 2001), Hurelbrink, C. B. et al. (Expert Opin Pharmacother, 2001), Arenas, E. (Brain Res Bull, 2002), McGrath, J. et al. (Cell Transplant, 2002), Dillon-Carter, O. et al. (Cell Transplant, 2002), Sanchez, B. et al. (Brain Res Mol Brain Res, 2002), Kordower, J. H. (Ann Neurol, 2003), Chen, X. et al. (Parkinsonism Relat Disord, 2003), Maruyama, W. et al. (Neurochem Int, 2004), Lo Bianco, C. et al. (Neurobiol Dis, 2004), Duan, D. et al. (Exp Brain Res, 2005), Muramatsu, S. et al. (Expert Opin Biol Ther, 2005), Dowd, E. et al. (Eur J Neurosci, 2005), Ericson, C. et al. (Eur J Neurosci, 2005), Eslamboli, A. (Rev Neurosci, 2005), Backman, C. M. et al. (Mol Cell Endocrinol, 2006), Jain, S. et al. (J Neurosci, 2006), Gasmi, M. et al. (Mol Ther, 2007), Tatarewicz, S. M. et al. (J Clin Immunol, 2007), Ebert, A. D. et al. (Exp Neurol, 2008), Xia, C. F. et al. (J Gene Med, 2008), Lucking, C. B. et al. (Neurobiol Aging, 2010), Deierborg, T. et al. (Prog Neurobiol, 2008), Eberling, J. L. et al. (Hum Gene Ther, 2009), Herzog, C. D. et al. (Neurosurgery, 2009), Yang, X. et al. (J Gene Med, 2009), Manfredsson, F. P. et al. (Curr Gene Ther, 2009), Alladi, P. A. et al. (J Chem Neuroanat, 2010), Manfredsson, F. P. et al. (Discov Med, 2010), Souza, R. P. et al. (Psychopharmacology (Berl), 2010), Yasuda, T. et al. (Expert Rev Neurother, 2010), Glavaski-Joksimovic, A. et al. (J Neurosci Res, 2010), Laganiere, J. et al. (J Neurosci, 2010), Pascual, A. et al. (J Mol Endocrinol, 2011), Decressac, M. et al. (Brain, 2011), Mickiewicz, A. L. et al. (CNS Neurol Disord Drug Targets, 2011), Kells, A. P. et al. (Neurobiol Dis, 2012), Drinkut, A. et al. (Mol Ther, 2012), Tai, K. et al. (PLoS One, 2012), Hickey, P. et al. (Expert Opin Biol Ther, 2013), Kordower, J. H. et al. (Mov Disord, 2013), Quintino, L. et al. (Mol Ther, 2013), Redmond, D. E. Jr et al. (Mol Ther, 2013), Sun, X. L. et al. (Mol Neurobiol, 2014), Deng, X. et al. (PLoS One, 2013), Kotyuk, E. et al. (PLoS One, 2013), Klein, P. et al. (EMBO J, 2014), Lu-Nguyen, N. B. et al. (Hum Gene Ther, 2014), Jeong, K. H. et al. (J Med Food, 2015), Smith, R. C. et al. (Exp Neurol, 2015), Domanskyi, A. et al. (Hum Gene Ther, 2015), Kordower, J. H. (Methods Mol Biol, 2016), Lindholm, D. et al. (Cell Mol Life Sci, 2016), Kumar, A. et al. (PLoS Genet, 2015), Dong, J. et al. (CNS Neurosci Ther, 2016), Espadas-Alvarez, A. J. et al. (Nanomedicine, 2017), Lin, L. F. et al. (Science, 1993), Choi-Lundberg, D. L. et al. (Science, 1997), Hunot, S. et al. (J Neural Transm (Vienna), 1996), Mandel, R. J. et al. (Proc Natl Acad Sci U S A, 1997), Lapchak, P. A. et al. (Brain Res, 1997), Walker, D. G. et al. (Brain Res, 1998), Wartiovaara, K. et al. (Exp Neurol, 1998), Choi-Lundberg, D. L. et al. (Exp Neurol, 1998), Bohn, M. C. (Biochem Pharmacol, 1999)
|
Adapter molecule crk
|
Crk |
Q64010 |
Parkinson Disease
|
|